ERBB2 and neoplasm: Despite the limited sample size of the non-basal-like groups (resulting into diminished statistical power) we could identify splicing-specific differences between basal-like and Luminal and HER2 subtypes, with plasma membrane receptors showing up again as specifically deregulated at splicing levels in basal-like tumours (complete results are listed in Additional File 9).